New Hope for BTK Inhibitor Intolerant Patients: Pirtobrutinib Shows Promise in B-Cell Malignancies
Pirtobrutinib demonstrates efficacy and tolerability in patients with B-cell cancers who couldn't tolerate other BTKis.
Meta-analysis reveals PD-1/PD-L1 inhibitors improve survival in advanced gastroesophageal cancers.
Meta-analysis shows PD-L1 levels predict immunotherapy efficacy in gastroesophageal adenocarcinoma
Meta-analysis reveals DPYD gene variants significantly increase death risk in fluoropyrimidine chemotherapy.
DOS chemotherapy improves tumor response in locally advanced gastric cancer compared to SOX regimen
Study suggests ramucirumab may benefit certain patients with advanced gastroesophageal cancer after immunotherapy
Immunotherapy drug sintilimab improves survival in advanced gastric cancer when added to chemotherapy.
Study shows pembrolizumab with chemotherapy improves outcomes in HER2-negative gastric cancer